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Appendix 1. Standards of Professional Behavior Policy TITLE: STANDARDS OF POLICY: The Nicole
Wertheim College of Nursing and Health Sciences (NWCNHS) will specify specific requirements, student
responsibilities and recommended guidelines regarding standards of professional behavior across all
nursing and health sciences programs within the college. RATIONALE: Standards of Professional
Behavior and Conduct Students in nursing and other health professions curricula are held to standards
of conduct that both differ from and exceed those usually expected of university students.
Consequently, NWCNHS students are required to demonstrate clinical competency, including
reasonable skill, safe practice, and professional behavior at all times, in the care of clients and clinical
rotation/field experience interactions. PROCEDURE: Students may be removed from program
experiences at any time for unsafe or unprofessional behavior. Further, students are required to adhere
to the standards of acceptable conduct outlined in their respective professional association code of
ethics and state of Florida professional regulations. Students can be removed from the nursing or health
sciences program of study and/or any college affiliate clinical site or organizations based on violation of
professional conduct. NWCNHS students are held to the basic expectations for personal and
professional behavior that all members of the FIU community should follow. Especially when faced with
a difficult situation or decision, consider, and apply the university’s core values of civility, respect, and
integrity. Breaches of conduct are reviewed and processed by the program chair referred to the Office
for Student Conduct and Academic Integrity in accordance with the procedures outlined in the FIU
Student Handbook. Resolutions of presented violations may include dismissal from the program.
Academic honesty and integrity are fundamental values that the Nicole Wertheim College of Nursing
and Health Sciences upholds. Any incident of academic misconduct will be handled according to the
guidelines of the FIU Office of Student Conduct and Academic Integrity. Additionally, any individual who
is aware of violations of the Honor code is bound by honor to report the incidence or violation to the
respective administration
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ABSTRACT
Background: Atherosclerotic cardiovascular disease (ASCVD) is a production of plaque buildup
in the arterial walls that can lead to a myocardial infarction (MI) or cerebrovascular accident
(CVA). Atherosclerosis can be caused by multiple of factors such as hyperlipidemia,
hypertension, and smoking. The ASCVD risk calculator follows a standardized educational
guideline for healthcare providers for recommendations to improve patient outcomes and
decrease complications. Utilization of the Nurse Practitioner (NP) for ASCVD management in a
primary office setting allows for improve medical management of ASCVD. Purpose:
Development of an NP-led educational program in the primary care setting to improve the
efficacy of health care providers knowledge on the ASCVD risk calculator and utilizing it into
practice. Participants: 6-9 healthcare providers in a South Florida primary care clinic. Method:
A quality improvement (QI) project with a pre- and post-design design measuring healthcare
providers self-efficacy scoring with the ASCVD Risk Calculator Questionnaire. Educational
guidelines given by a voiceover PowerPoint. Information is based on the ASCVD Risk
Calculator created by the American Heart Association and American College of Cardiology.
Results: Nine healthcare providers completed pretest and six completed the posttest. Based on
the assessment clinical knowledge questions there was an increased knowledge of the ASCVD
risk calculator.. Discussion: The primary healthcare providers had increased knowledge and
awareness of the ASCVD Risk Calculator. Limitations of the pilot study was having a small
sample size, the responses of the healthcare providers returning for posttest, and the anonymity
of the participants.
Keywords: Atherosclerotic cardiovascular disease, ASCVD, healthcare providers, ASCVD Risk
Calculator
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I.

Introduction/Problem Statement/Significance

The nature of the problem is prevention of a myocardial infarction (MI) or cerebrovascular
accident (CVA) by screening cholesterol levels and risk factors using the ASCVD Risk
Calculator. The scope of this problem is important, as the risk for MIs an CVAs could be
identified more quickly and treated in an efficient matter. The current institution policy for
treating hyperlipidemia is based on the facilities protocol. The South Florida Clinic currently
does not have all the health care providers consistently using the ASCVD Risk Calculator for
their primary outpatient facilities that can detect patients that have an increased cardiovascular
risk. The ASCVD Risk Calculator is not used routinely in the primary care setting, but it is an
essential tool to assist providers.
Stroke or CVA is the fifth leading cause of death for Americans (Center for Disease Control
and Prevention, 2020). In 2018, one in every six deaths were from cardiovascular diseases that
caused a stroke (Center for Disease Control and Prevention, 2020). For MI’s, approximately 1.5
million cases occur annually in the United States (Zafari & Yang, 2019). The yearly incidence
rate of MI’s is approximately 600 cases per 100,000 people (Zafari & Yang, 2019). The death
rate related to acute MI is approximately three times higher in men than in women (Zafari &
Yang, 2019). The cost for not addressing the risk factors for not reducing cardiovascular risk is
in the billions. Stroke-related costs in the United States were nearly 46 billion between 2014 and
2015 (Center for Disease Control and Prevention, 2020). Hospital costs for MI’s that are
classified as STEMI and non-STEMI are averaged to $19,327 for STEMI and $18, 465 for nonSTEMI (Cowper et al., 2019). The dilemma of not identifying patients that have increased
cardiovascular risk by screening cholesterol levels and risk factors would increase the cost of
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healthcare. Incorporating the ASCVD Risk Calculator into the healthcare provider’s daily tasks
would improve the utilization of the screening tools and patient’s cardiovascular health. The
study would contribute to the solution of the problem by providing awareness of the evidencebased screening tool of the ASCVD Risk Calculator on its affectability of detecting and treating
patients with a risk of cardiovascular disease.
II.

Summary of the Literature
The following questions that will be investigated in the study will be: Is there a

compliance matter for providers understanding the ASCVD Risk Calculator and utilizing it; and
will repetitive education improve providers efficiency by using the ASCVD (Atherosclerotic
Cardiovascular Disease) risk calculator in practice? The goal is to improve the knowledge base
of providers in primary care settings of the ASCVD Risk Calculator during a three-month period.
The literature review focuses on the cholesterol levels that correlate to the stain treatment and
lifestyle modifications when utilizing the ASCVD Risk Calculator.
Literature Search
The literature search involved the identification of the keywords associated with the
PICO question, “Will educating the providers on the use of the universal ASCVD Risk
Calculator improve the efficacy of their knowledge of the calculator and utilizing it into
practice.” The key words and the Boolean search terms were utilized in the literature review. The
key words that were included in the search are: “ascvd risk calculator” OR “atherosclerotic
cardiovascular disease risk” or “cardiovascular risk”; “patient compliance” AND
“hyperlipidemia” OR “hyperlipidemia medication” OR “cholesterol levels” OR “systematic
review on cardiovascular risk” OR “meta-analysis on cardiovascular risk;” “cardiovascular risk”
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AND “morbidity rate”, “cardiovascular risk” AND “mortality rate,” “ASCVD risk calculator”
AND “prevention”, “atherosclerotic cardiovascular disease risk” AND “prevention.”
The search for the literature articles included Boolean/Phrase search terms, full text,
publication date from January 2016 to January 2021, English language, and human subjects. The
search engines used were CINAHL (Cumulative Index to Nursing and Allied Health Literature)
Plus with Full Text, Cochrane Library, PubMed, and Google. The searches displayed systematic
reviews and meta-analyses. The search engine that yields the most research articles according to
the PICO question was PubMed of 276 results with respective limitations of not including
systematic reviews and meta-analyses which shown to decrease the number of valuable results.
The Cochrane Library had displayed one Cochrane review and 38 trials. CINAHL had generated
30 research articles. When including systematic reviews and meta-analyses as a filter for the
searches, this limited the results of all the search engines. Google was used to give a broader
search for literature articles that were on various sites that were given access to the public.
Literature Review
“Systematic Review for the 2018
AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on
the Management of Blood Cholesterol: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines” is a Level
III with high quality data based on the John Hopkins Nursing Evidence-Based Practice (2017).
The research article is a level III based on being a systematic review with a combination of
randomized controlled trials. The article is high quality for having consistent, generalized results,
sufficient sample size, definitive conclusions, and consistent recommendations based on
comprehensive literature (The Johns Hopkins Hospital/ Johns Hopkins University School of
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Nursing, 2017). The sample size of the study was over 1000 patients designed for a follow-up in
one year. The researchers identified ten randomized controlled trials to include the differences of
treatment of hyperlipidemia. The results of the study were able to show evidence for adding nonstatin lipid-modifying therapies to statins to decrease ASCVD risk.
“Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular
diseases” meets the criteria of a Level III. The article relates to the objective of finding the
effects of fixed-dosed combination therapy that can lead to fatal and non-fatal ASCVD events
(Bahiru et al., 2017). The researchers used nine randomized controlled trials and four clinical
trials. The sample size was a total of 7047 participants from the randomized controlled trials and
2021 from the clinical trials. This literature article is of good quality due to the lack of a
comprehensive literature review although there was a reasonably consistent recommendation.
The data gathered from the researchers presented the effects of fixed-dose combination drug
therapy were uncertain to cause ASCVD events that leads to a need of ongoing, longer-term
trials (Bahiru et al., 2017)..
“Predicting Risk of Atherosclerotic Cardiovascular Disease Using Pooled Cohort
Equations in Older Adults With Frailty, Multimorbidity, and Competing Risks” is a lower
quality literature article when compared to the previously discussed ones. This article is a Level I
and good quality. The literature article was a longitudinal experimental study with a sample size
of 4249 participants. The article had many limitations of overestimating the pool cohort equation
performance and self-reported surveys for the participants and physicians which lead to
individual bias (Nguyen et al., 2020). Overall, the study was able to show the calibration and
discrimination were good for the population aged over 65 that utilized the ASCVD risk tool.
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Also, that there is a need for a more accurate ASCVD risk tool for participants with
multimorbidity class and frailty status (Nguyen et al., 2020).

Chart 1

Literature Search of Databases:
CINAHL, Pubmed and Cochrane, Google

Search Results
N = 345

Studies screened regarding relevancy to PICO

Excluded Studies
N = 326
Unrelated Research, N = 300
Unrelated Literature Reviews, N = 22
Duplicates, N = 2

Studies Included
N = 19
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III.

PICO Clinical Question
The PICO clinical question: Will educating the providers on the use of the universal

ASCVD risk calculator improve the efficacy of their knowledge of the calculator and
utilizing it into practice?
IV.

Definition of Terms

ASCVD (Atherosclerotic cardiovascular disease) Risk Score: is a national guideline that
calculates the ten-year risk of developing a cardiovascular problem such as a myocardial
infarction or cerebrovascular attack (Intermountain Healthcare, 2019)
Hyperlipidemia: is an umbrella term for genetic and acquired disorders that defines elevated lipid
levels within the body (Hill & Bordoni, 2021).
Myocardial Infarction: also known as a heart attack is a permanent damage to the heart muscle
due to a lack of blood supply (Cleveland Clinic, 2019).
Cerebrovascular accident: also known as a stroke that occurs when there is a loss of blood flow
to the brain (Medline Plus, 2021).
V.

Conceptual Underpinning and Theoretical Framework of the Project

The conceptual framework that will be utilized is the Donabedian Quality-of-Care (QOC)
model. The Donabedian QOC identifies three domains that relate to efficient patient quality of
care which are structure, process, and outcome (LoPorto, 2020). The domains are used to
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measure and compare the quality of health care organizations when it comes to resources,
practices, and results. The structure measures the healthcare provider’s capacity, the process
measures what a provider does to maintain or improve health, and outcome reflects the impact of
a health care intervention that is affecting the health status of the patient (Agency for Healthcare
Research, 2015). When pertaining to the study the structure is how to establish and implement
the awareness of the ASCVD Risk Calculator in the South Florida Clinic day-to-day patient care.
The process would be the implementation of the ASCVD risk calculator by educating the
providers so that it can be used in practice. The outcomes are the result of using the ASCVD
Risk Calculator from increased awareness and seeing if it effective and accommodating to the
providers.
The nursing theory that will be utilized is the Health Promotion Model designed by Nola J.
Pender. The Health Promotion Model identifies health as the positive aspect rather than the
absence of disease (Petiprin, 2020). Health promotion is the primary goal of the model with the
focus for providers to utilize the ASCVD Risk Calculator that will promote change in the
behavioral outcome of providers using a screening tool in practice for patients with
hyperlipidemia and mixed hyperlipidemia. The Health Promotion Model makes four
assumptions (Petiprin, 2020):
1. Individuals seek to actively regulate their own behavior.
2. Individuals, in all their biopsychosocial complexity, interact with the environment,
progressively transforming the environment as well as being transformed over time.
3. Health professionals, such as nurses, constitute a part of the interpersonal environment,
which exerts influence on people through their life span.
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4. Self-initiated reconfiguration of the person-environment interactive patterns is essential
to change behavior.
VI.

Methodology
A. PDSA Cycle

The PDSA cycle is the Plan-Do-Study Act cycle. The PDSA cycle is used to decide the
proposed change that will result in improvement and to evaluate that change (Institute for
Healthcare Improvement, 2021).
•

Plan: A pre-survey given to providers for the ASCVD risk calculator. Providers will be
educated on the ASCVD Risk Calculator, medication compliance, and cultural
competency.

•

Do: The provider, after diagnosing hyperlipidemia, will use the ASCVD risk calculator.

•

Study: The provider will be reevaluated on how well their knowledge base is of the
ASCVD Risk Calculator and how to use it effectively.

•

Act: The provider will continue using the ASCVD Risk Calculator for the rest of the
panel and utilize the recommendations. An end survey will be given to the providers.
B. Plan:
I.

Study design: Quantitative pre and post-test design

II.

Setting: South Florida clinic

III.

Sample: Nine healthcare providers of Medical Doctors (MDs)/Doctor of
Osteopathy(DOs) and Nurse Practitioners

IV.

Intervention: The participants will be given a pre-test survey. The pre-test
results will be used to create a targeted voice-over PowerPoint presentation
education intervention based on the results of a related systematic review.
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Participants will then be provided with an electronic link to view the voiceover PowerPoint educational session, which is expected to last approximately
20-30 minutes. Participants will then be electronically linked to the post-test
immediately after the educational intervention.
V.

Measurement: The instruments that will be used are Qualtrics survey for the
providers for the evaluation of the ASCVD risk calculator, medication
compliance, and cultural competency. The screening tool for measuring the
risk score is the American College of Cardiology ASCVD Risk Estimator
Plus.

VI.

Data Collection: The collection of the data is the participants pre- and posttest survey results are online utilizing the Qualtrics surveys.

VII.

Data analysis: Qualtrics, Microsoft Excel, and T-test calculator for P-value
calculations

VIII.

Protection of Human Subjects: A voluntary informed consent recruitment
letter will be given to the providers of the South Florida clinic. The
Institutional Review board given the approval of the project to make sure
HIPAA compliance is ensured.

VII.

Results

The findings of the pre- and post-test showed there was an increased understanding of the
ASCVD risk calculator when pertaining to the assessment’s clinical knowledge questions
that were being measured. The other questions in the survey were opinion-based and not
measured. For the demographics, the pre-test had nine providers, and of the nine providers
six were Hispanic women and three were Hispanic men. For the professions, four were
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Advanced Practice Registered Nurses and five were Medical Doctors/Doctor of Osteopathic
Medicine. See Figure One and Figure Two on in-depth demographics. The result of the twotailed paired samples t-test with the p value <0.001. This evidenced through the mean of the
pre-test scores and post-test scores being significant different than zero with the standard
deviation in the post-test being significant less than that in the pretest (0.087841046 is the
pre-test vs 0.068041382 in the post-test). t was significant based on an alpha value of 0.005.
Figure Four displays the correct percentages of the survey questions. See Figure Three for
the visualization of correct and incorrect answers of the survey. For question seven: ASCVD
risk calculator is primary prevention? (True/False) on the pre-test 9/9 participants (100%)
answered True and on the post-test 6/6 participants (100%) answered True; question eight:
For the ASCVD risk calculator there is age limit of utilization for risk score? (True/False) for
the pre-test 8/9 participants (88%) answered True and for the post-test 5/6 participants (83%)
answered True; question nine: Do you what ASCVD stands for? A. Arterial Cardiovascular
Disease, B. Atherosclerotic Cardiovascular Disease, C. Aortic Cardiovascular Disease, and
D. Aortic Coronary Disease for the pre-test 9/9 participants (100%) answered B.
Atherosclerotic Cardiovascular Disease and the post-test 6/6 participant (100%) answered B.
Atherosclerotic Cardiovascular Disease; question ten: Who created the ASCVD risk
calculator? A. United States Preventative Services Task Force, B. American Academy of
Family Physicians, C. American College of Cardiology, and D. Aortic Coronary Disease for
the pre-test 6/9 participants (67%) answered C. American College of Cardiology and the
post-test 6/6 participants (100%) answered C. American College of Cardiology; question
eleven: Atherosclerosis is caused by all except: A. High Blood Pressure, B. Exercise, C. High
Cholesterol, and D. Smoking for the pre-test 9/9 participants (100%) answered B. Exercise
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and post-test 6/6 participants (100%) answered B. Exercise; question twelve: Having a high
ASCVD risk score can lead to all except: A. Myocardial Infarction, B. Cerebrovascular
Accident, C. Death, and D. Irritable Bowel Syndrome for pretest 9/9 participants (100%)
answered D. Irritable Bowel Syndrome and post-test 6/6 participants (100%) answered D.
Irritable Bowel Syndrome. When viewing an overall of the pre-test and post-test the
healthcare providers understood the ASCVD risk calculator and were likely to use it in
practice.
VIII.

Discussion

The primary healthcare providers had increased knowledge and awareness of the ASCVD
Risk Calculator after the educational intervention for treating patients with hyperlipidemia.
The limitations of the pilot study were having a small sample size, the responses of the
healthcare providers returning for post-test, and the anonymity of the participants. The South
Florida Clinic was going through a change of ownership during the time of the pilot study
which caused delays for the health care providers responding to the pre-test and post-test.
Furthermore, the Covid-19 pandemic contributed to some of the delays of the study because
healthcare providers were busier with patient care, and many would forget to check their
emails daily. Daily emails were sent to providers for the pre-test and post-test, but there were
still difficulties in getting a response from the providers which led to repetitive emails to
providers that already finished the survey, and the clinical investigator was unaware which
provider completed the survey due to anonymity. The improvement that could have been
done in this pilot study are setting up a video chat meeting for all the healthcare providers
that wanted to participate and provider the pretest, PowerPoint, and posttest in one day as this
could have guaranteed an equal number of participants.
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IX.

Advanced Nursing Practice Implications
The implications for advance practice nursing are the utilization of screening tools in

the primary care setting. All healthcare providers should be aware of the ASCVD Risk
Calculator and ASCVD risk score as it is a useful screening tool to educate the public on
cardiovascular health.. Also, the ASCVD Risk Calculator can give a visualization for patients
and providers of the risk score with evidence-based information on lifestyle modifications
and statin treatment for preventative measures.
X.

Conclusions
ASCVD Risk Calculator is a valuable screening tool for healthcare professionals in

the primary care setting as it can assist in making decisions on the proper medication and
lifestyle choices that can reduce the risk for atherosclerotic disease. Screening tools are
meant as a guide for providers and patients for educational information. The success of this
pilot study identifies an opportunity to provide more awareness to providers about the
ASCVD Risk Calculator tool and its use in treating hyperlipidemia. Increased utilization of
tools like the ASCVD Risk Calculator are useful for both the provider and patient to
visualize the risk for ASCVD, and understand the treatment advised from evidence-based
guidelines.
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PRETEST-POSTTEST
“Educating Providers of the ASCVD Risk Calculator in a Primary Care Setting: A Quality
Improvement Project”
Introduction:
This questionnaire is an essential part of a quality improvement project aiming to
increase healthcare provider knowledge of the ASCD risk calculator for patients with
hyperlipidemia and mixed hyperlipidemia.
Please answer to the best of your knowledge. Your response will help to understand gaps
in knowledge and room for improvement. The questions are structured to assess your
understanding of ASCVD risk calculator, medication compliance, and cultural competency.
•
•
•

Please do not write your name or other personal information on this questionnaire
Your answers are anonymous and will be kept confidential
Your participation is voluntary and will not have any bearing on your position

Demographic:
Gender: Female ______ Male______ Other______ Wish not to disclose_____
Age: 20-30 yrs._____ 30-40 yrs._____ 40-50 yrs._____ >50 yrs._____
Clinical Position: MD/DO_____ APRN_____ PA_____
Years of experience: 0-1 years_____ 1-3 years_____ 3 or more_____
Ethnicity: White_____ Black_____ Hispanic_____ Asian_____ Other_____

Questionnaire:
1. Have you received any training on ASCVD Risk calculator in any form?
_____Yes

_____No

2. Do you have discussions about ASCVD risk score with your patients?
_____Yes

_____No

3. In primary care, have you ever incorporated clinical tools into practice?
_____Yes

_____No
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4. Please respond to the following statements:
Statement

Strongly
Agree

Agree

Undecided

Disagree

Strongly
Disagree

Undecided

Disagree

Strongly
Disagree

Undecided

Disagree

Strongly
Disagree

I am familiar with
ASCVD

5. Please respond to the following statements:
Statement

Strongly
Agree

Agree

I am familiar with
ASCVD risk calculator

6. Please respond to the following statements:
Statement

Strongly
Agree

Agree

I am confident in my
ability to discuss
ASCVD risk score with
my patients
Assessment of Clinical Knowledge
True or False
7. ASCVD risk calculator is primary prevention?
_____True

_____False

8. For the ASCVD risk calculator there is age limit of utilization for risk score?
_____True
9. Do you know what ASCVD stands for?
a. Arterial Cardiovascular Disease
b. Atherosclerotic Cardiovascular Disease
c. Aortic Cardiovascular Disease
d. Aortic Coronary Disease

_____False
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10. Who created the ASCVD Risk calculator?
a. United States Preventative Services Task Force
b. American Academy of Family Physicians
c. American College of Cardiology
d. Centers for Disease Control and Prevention

11. Atherosclerosis is caused by all except:
a. High Blood Pressure
b. Exercise
c. High Cholesterol
d. Smoking
12. Having a high ASVD risk score can lead to all except:
a. Myocardial Infarction
b. Cerebrovascular Accident
c. Death
d. Irritable Bowel Syndrome

Medication Compliance & Cultural Sensitivity
13. Please respond to the following statements:
Statement

Strongly
Agree

Agree

Undecided

Disagree

Strongly
Disagree

Undecided

Disagree

Strongly
Disagree

How likely are you to
use the ASCVD risk
calculator?
14. Please respond to the following statements:
Statement

Strongly
Agree

Agree

Do you think ASCVD
risk calculator will
slow down productivity
in practice?
15. Do you think ASCVD risk score will help patients with medication compliance?
_____True

_____False
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16. Which communication technique is most effective when speaking with patients?
a) Closed loop
b) Open-ended
c) Accusatory
d) Call-out
17. Please respond to the following statements:
Statement
Do you think culture
plays a big factor in
treatment
recommendations?

Strongly
Agree

Agree

Undecided

Disagree

Strongly
Disagree

